DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bromax (Brompheniramine Maleate) - Summary



Bromax Tablet contains Brompheniramine Maleate, an antihistamine.

Bromax (Brompheniramine Maleate) is indicated for the temporary relief of symptoms associated with seasonal and perennial allergic rhinitis and vasomotor rhinitis.
See all Bromax indications & dosage >>


Media Articles Related to Bromax (Brompheniramine)

Allergic Rhinitis: 3 Years of Immunotherapy Needed
Source: Medscape Allergy & Clinical Immunology Headlines [2017.02.14]
When treatment was shortened from 3 years to 2, sublingual immunotherapy proved no better than placebo for patients with grass pollen allergy.
Medscape Medical News

Hay Fever (Allergic Rhinitis)
Source: MedicineNet Allergic Cascade Specialty [2016.10.07]
Title: Hay Fever (Allergic Rhinitis)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 10/7/2016 12:00:00 AM

Chronic Rhinitis and Post-Nasal Drip
Source: MedicineNet Allergy Treatment Begins At Home Specialty [2016.09.14]
Title: Chronic Rhinitis and Post-Nasal Drip
Category: Diseases and Conditions
Created: 7/13/1998 12:00:00 AM
Last Editorial Review: 9/14/2016 12:00:00 AM

more news >>

Clinical Trials Related to Bromax (Brompheniramine)

Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents [Completed]
The objective of this study is to characterize the pharmacokinetic (PK) profile of brompheniramine maleate (BROM) in children and adolescents, ages 2 to less than 18 years following dosing in accordance with current weight-age dosing guidelines. Once characterized, the PK data will be pooled with adult PK data from other studies and analyzed under a separate analysis plan to confirm or refine the existing OTC doses in children aged 2 to <12 yrs and adolescents aged 12 to <18 yrs.

Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis [Not yet recruiting]
Multicenter clinical trial, phase III, controlled by active medicine, open, randomized, enroll 962 children, 2 to 12 years old, that suffer acute inflammation upper airway characterized by non-productive cough, daytime/nighttime, with duration for at least 3 and no more than 5 consecutive days (without systemic/topic use of medication during this period) followed by nasal congestion, with or without associate other nasal symptoms (sneezing, runny nose, nasal itching and/or mouth breathing). The subjects will be allocated in 2 parallel groups, and will receive the medicines of study, according of the randomization.

Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis [Not yet recruiting]
This is a multicenter clinical trial, phase III, superiority, controlled by active medicine, double-blind, randomized, enroll 166 children, over 12 years old, with acute inflammation upper airway, characterized by nasal congestion and runny nose, lasting at least 24 hours and a maximum of 48 hours prior to inclusion. The subjects will be allocated in 2 parallel groups, and will receive the medicines of study, according of the randomization.

more trials >>

Page last updated: 2017-02-14

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015